BRAIN Biotech AG Long-term Investment Intensity
BRAIN Biotech AG long-term investment intensity. BRAIN Biotech AG (BNN) has a Long-term Investment Intensity of 2.2% as of September 2019. Long-term investments of €1.44 Million represent 2.2% of total assets of €66.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read BRAIN Biotech AG balance sheet liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of BRAIN Biotech AG (2014–2019)
Long-term investment intensity of BRAIN Biotech AG from 2014 to 2019. This chart shows how BRAIN Biotech AG's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 2.2%, reflecting long-term investments of €1.44 Million against total assets of €66.12 Million EUR.
BRAIN Biotech AG Long-term Investment Intensity by Year (2014–2019)
BRAIN Biotech AG long-term investment intensity by year from 2014 to 2019. The table below presents the year-by-year Long-term Investment Intensity for BRAIN Biotech AG from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BNN total assets.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.2% | €1.44 Million | €66.12 Million | ▼ -0.5 pp |
| 2018 | 2.7% | €1.98 Million | €74.46 Million | ▲ +2.4 pp |
| 2017 | 0.2% | €166.00K | €68.50 Million | ▼ -0.1 pp |
| 2016 | 0.4% | €168.00K | €47.51 Million | ▲ +0.4 pp |
| 2015 | 0.0% | €2.00 | €30.41 Million | ▼ -0.6 pp |
| 2014 | 0.6% | €158.64K | €25.07 Million | — |